COGT - Cogent Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$51.75
DETAILS
HIGH:
$55.00
LOW:
$45.00
MEDIAN:
$53.50
CONSENSUS:
$51.75
UPSIDE:
54.89%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 922,479 | $35.7M | 0.0% | -945,910 | DECREASED |
| Wood | 744,195 | $28.8M | 0.0% | -666,631 | DECREASED |
| Druckenmiller | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-27 | Morris Arlene | director | M-Exempt | 3,583 | $2.52 | $9K |
| 2026-08-27 | Morris Arlene | director | M-Exempt | 41,927 | $5.64 | $236K |
| 2026-08-27 | Morris Arlene | director | SELL | 42,349 | $37.09 | $1.6M |
| 2026-08-27 | Morris Arlene | director | SELL | 3,161 | $37.54 | $119K |
| 2026-07-01 | Ferrante Karen Jean | director | A-Award | 627 | $38.48 | $24K |
| 2026-06-09 | Morris Arlene | director | A-Award | 17,901 | $31.98 | $572K |
| 2026-06-09 | CAIN CHRISTOPHER W. | director | A-Award | 17,901 | $31.98 | $572K |
| 2026-06-09 | Shegog Todd | director | A-Award | 17,901 | $31.98 | $572K |
| 2026-06-09 | Ros Matthew | director | A-Award | 17,901 | $31.98 | $572K |
| 2026-06-09 | Harwin Peter Evan | director | A-Award | 17,901 | $31.98 | $572K |
| 2026-06-09 | Ferrante Karen Jean | director | A-Award | 17,901 | $31.98 | $572K |
| 2026-05-19 | Robbins Andrew R | director, officer: President and CEO | G-Gift | 160,000 | -- | -- |
| 2026-04-01 | Ferrante Karen Jean | director | A-Award | 686 | $35.24 | $24K |
| 2026-03-31 | Fairmount Funds Management LLC | director | C-Conversion | 7,000,000 | -- | -- |
| 2026-03-31 | Fairmount Funds Management LLC | director | SELL | 7,000,000 | $34.66 | $242.6M |
| 2026-03-31 | Fairmount Funds Management LLC | director | C-Conversion | 28,000 | -- | -- |
| 2026-01-22 | Fairmount Funds Management LLC | director | SELL | 3,500,000 | $36.40 | $127.4M |
| 2026-01-01 | Ferrante Karen Jean | director | A-Award | 643 | $34.74 | $22K |
| 2025-12-26 | Green John L. | officer: Chief Financial Officer | SELL | 77,000 | $38.68 | $3.0M |
| 2025-12-26 | Sachs Jessica | officer: Chief Medical Officer | SELL | 82,642 | $38.70 | $3.2M |
| 2025-12-26 | Robinson John Edward | officer: Chief Scientific Officer | SELL | 90,000 | $38.74 | $3.5M |
| 2025-12-26 | Kearns Evan | officer: Chief Legal Officer | SELL | 65,000 | $38.70 | $2.5M |
| 2025-12-17 | Robinson John Edward | officer: Chief Scientific Officer | A-Award | 65,000 | $39.45 | $2.6M |
| 2025-12-17 | Robinson John Edward | officer: Chief Scientific Officer | F-InKind | 139,998 | $39.45 | $5.5M |
| 2025-12-17 | Robinson John Edward | officer: Chief Scientific Officer | A-Award | 50,000 | -- | -- |